Daewoong Pharmaceutical Co., Ltd.;Dong-A University Research Foundation for Industry-Academy Cooperation
发明人:
申请号：
EP15799167.0
公开号：
EP3148570A4
申请日:
2015.05.14
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Provided is a method for preventing or treating skin rash comprising administering to a subject in need thereof epidermal growth factor as an active ingredient. The skin rash includes a skin disorder caused by administering an epidermal growth factor receptor inhibitor, such as erlotinib, as an adverse event.
